Genetically modified anti-third party central memory T cells and use of same in immunotherapy
US11844827B2 · kind B2 · utility
0Cited by
18References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2021 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Nov 22, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An isolated cell having a central memory T-lymphocyte (Tcm) phenotype, the cell being tolerance-inducing cell and capable of homing to the lymph nodes following transplantation, the cell being transduced to express a cell surface receptor comprising a T cell receptor signaling module is disclosed. Methods of generating same and using same are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.